Xenon Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Xenon Pharmaceuticals Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2019 to Q3 2025.
  • Xenon Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending September 30, 2025 was $1.79M, a 1.32% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)

Xenon Pharmaceuticals Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.79M -$24K -1.32% Sep 30, 2025 10-Q 2025-11-03
Q2 2025 $1.8M -$8K -0.44% Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $1.74M -$76K -4.19% Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $1.76M -$13K -0.74% Dec 31, 2024 10-K 2025-02-27
Q3 2024 $1.82M +$72K +4.13% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.8M +$36K +2.04% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.82M +$67K +3.83% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.77M +$91K +5.43% Dec 31, 2023 10-K 2024-02-29
Q3 2023 $1.74M +$853K +95.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.77M +$812K +84.9% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.75M +$763K +77.5% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.68M +$745K +79.9% Dec 31, 2022 10-K 2023-03-01
Q3 2022 $890K +$319K +55.9% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $956K +$372K +63.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $985K +$409K +71% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $932K +$238K +34.3% Dec 31, 2021 10-K 2022-03-01
Q3 2021 $571K +$524K +1115% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $584K -$3K -0.51% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $576K +$9K +1.59% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $694K +$80K +13% Dec 31, 2020 10-K 2021-03-01
Q3 2020 $47K -$574K -92.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $587K -$34K -5.48% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $567K -$54K -8.7% Mar 31, 2020 10-Q/A 2020-05-26
Q4 2019 $614K Dec 31, 2019 10-K 2020-03-09
Q3 2019 $621K Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $621K Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $621K Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.